VCNX (VCNX) Stock Price & Analysis
VCNX (VCNX) rose 0.00% to USD 0.75 as of September 8, 2026 at 09:05 UTC, according to Nexqual real-time market data.
VCNX last closed at USD 0.75; the session ranged USD 0.75–0.75 on volume of 1 shares. Market capitalization is —, with a 52-week range of USD 0.31–1.5 (PNK). Source: Nexqual, September 8, 2026 at 09:05 UTC.
Key Statistics (as of September 8, 2026 at 09:05 UTC)
| Price | USD 0.75 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.75 |
| Open | USD 0.75 |
| Day Range | USD 0.75 – 0.75 |
| 52-Week Range | USD 0.31 – 1.5 |
| Volume | 1 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (VCNX)
Nexqual's technical model rates VCNX "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:05 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 39.78 (neutral) |
| vs SMA50 | Below (USD 1.04) |
| MACD | -0.05 (negative) |
From VCNX's Latest SEC 10-K Filing (filed 2025-04-15)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ENTX | Entera Bio Ltd. | USD 3 | ▲ 2.74% |
| ATHE | Alterity Therapeutics Limited | USD 4.54 | ▲ 0.44% |
| ATXI | Avenue Therapeutics, Inc. | USD 0.54 | ▼ 4.56% |
| ARDS | Aridis Pharmaceuticals Inc. | USD 0 | ▲ 0% |
| ADIL | Adial Pharmaceuticals, Inc | USD 7.12 | ▲ 12.66% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:05 UTC. This page is informational and not investment advice.